Jacob Chacko Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jacob Chacko.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jacob Chacko. Jacob Chacko is Chief Financial Officer in Ignyta, Inc. ($RXDX) and Director in Turning Point Therapeutics, Inc. ($TPTX) and President and CEO in Oric Pharmaceuticals, Inc. ($ORIC).
Latest Insider Trading Transactions of Jacob Chacko
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, RXDX, ORIC, TPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.07 | 400 | 10,028 | 22,732 | 23.1 K to 22.7 K (-1.73 %) |
| May 13 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.04 | 730 | 18,281 | 58,180 | 58.9 K to 58.2 K (-1.24 %) |
| May 13 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.02 | 400 | 10,010 | 58,910 | 59.3 K to 58.9 K (-0.67 %) |
| May 13 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.22 | 1,090 | 27,490 | 59,310 | 60.4 K to 59.3 K (-1.80 %) |
| Apr 30 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.24 | 600 | 15,143 | 60,400 | 61 K to 60.4 K (-0.98 %) |
| Apr 30 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.06 | 700 | 17,542 | 61,000 | 61.7 K to 61 K (-1.13 %) |
| Apr 05 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.09 | 800 | 20,070 | 61,700 | 62.5 K to 61.7 K (-1.28 %) |
| Feb 02 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Option Exercise | A | 29.83 | 280,000 | 8,352,400 | 280,000 | |
| Jun 17 2020 | TPTX | Turning Point Ther ... | Chacko Jacob | Director | Option Exercise | A | 65.39 | 8,500 | 555,815 | 8,500 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Option Exercise | C | 0.00 | 62,500 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Buy | C | 0.00 | 62,500 | 0 | 62,500 | 0 to 62.5 K |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Option Exercise | A | 16.00 | 437,500 | 7,000,000 | 437,500 | |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Chacko Jacob | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Feb 12 2018 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Option Exercise | D | 5.60 | 50,000 | 280,000 | 0 | |
| Feb 12 2018 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Option Exercise | D | 6.58 | 25,200 | 165,816 | 0 | |
| Feb 12 2018 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Option Exercise | D | 7.40 | 250,000 | 1,850,000 | 0 | |
| Feb 12 2018 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Sell | D | 27.00 | 70,572 | 1,905,444 | 0 | 70.6 K to 0 (-100.00 %) |
| Jan 05 2018 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Grant | A | 0.00 | 4,400 | 0 | 70,572 | 66.2 K to 70.6 K (+6.65 %) |
| Dec 22 2017 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Grant | A | 0.00 | 23,334 | 0 | 66,172 | 42.8 K to 66.2 K (+54.47 %) |
| Jan 06 2017 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Option Exercise | A | 5.60 | 50,000 | 280,000 | 50,000 | |
| Mar 21 2016 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Buy | P | 5.64 | 10,000 | 56,350 | 42,838 | 32.8 K to 42.8 K (+30.45 %) |
| Jan 11 2016 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Grant | A | 0.00 | 26,400 | 0 | 32,838 | 6.4 K to 32.8 K (+410.07 %) |
| Dec 17 2015 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Buy | P | 12.00 | 1,500 | 18,000 | 6,438 | 4.9 K to 6.4 K (+30.38 %) |
| Aug 21 2015 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Grant | A | 12.40 | 1,500 | 18,600 | 4,938 | 3.4 K to 4.9 K (+43.63 %) |
| Jan 09 2015 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Option Exercise | A | 6.58 | 25,200 | 165,816 | 25,200 | |
| Nov 24 2014 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Buy | P | 6.50 | 930 | 6,045 | 3,438 | 2.5 K to 3.4 K (+37.08 %) |
| Nov 24 2014 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Buy | P | 6.40 | 668 | 4,275 | 2,508 | 1.8 K to 2.5 K (+36.30 %) |
| Aug 19 2014 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Buy | P | 7.53 | 1,540 | 11,596 | 1,840 | 300 to 1.8 K (+513.33 %) |
| Aug 19 2014 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Buy | P | 7.50 | 300 | 2,250 | 300 | 0 to 300 |
| May 30 2014 | RXDX | Ignyta, Inc. | Chacko Jacob | Chief Financial Off ... | Option Exercise | A | 7.40 | 250,000 | 1,850,000 | 250,000 |
Page: 1